A Study to Investigate the Safety and Efficacy of a Novel Furosemide Regimen
Status:
Withdrawn
Trial end date:
2017-03-07
Target enrollment:
Participant gender:
Summary
This is a, prospective, single center, open-label, pilot study to evaluate the safety and
efficacy of the subcutaneous administration of a novel furosemide formulation. The results of
this pilot study will be reviewed to determine the safety of the subcutaneous treatment
regimen and to evaluate patient selection criteria for possible at home treatment. The intent
is to conduct a future follow on study looking at the feasibility of at home treatment of
patients referred to a hospital for treatment of fluid overload.